Equipment Acquisition and Remarketing

BridgePath Scientific offers Equipment Acquisition and Remarketing

About Us

BridgePath Scientific is a Veteran-owned small business located in Frederick, Maryland. BridgePath has been servicing the global life sciences community since 2006. We welcome you to explore our site and please feel free to contact us for any of your needs.

Contact Us
News
Careers


Recent Information

Clients in the News – RoosterBio Launches the Regenerative Medicine Industry’s First Xeno-Free hMSC Cell Banks to Advance and Simplify Stem Cell Biomanufacturing

At a CAGR of 23.2% and estimated revenue of $68B by 2020, the Regenerative Medicine (“RM”) industry continues to call for new tools designed to accelerate this aggressive growth. Based on strong RM market demand, RoosterBio Inc today announces the launch of xeno-free (“XF”) human bone-marrow derived mesenchymal stem/stromal cell (hMSC) products. The RoosterVial™-XF line […]

Clients in the News – UMinn, 3D-bioprinted Patch Helps Heal Scarred Heart Tissue After Heart Attack

  When a person experiences a heart attack, blood flow to the heart muscle is lost and cells die. Since these heart muscle cells cannot be replaced, scar tissue forms in the heart, putting patients at risk for future heart failure or faulty heart function. Now, biomedical engineers from the University of Minnesota have created […]

Clients in the News – UCONN Researchers find Chili Pepper and Marijuana Calm the Gut

You wouldn’t think chili peppers and marijuana have much in common. But when eaten, both interact with the same receptor in our stomachs, according to a paper by UConn researchers published in the April 24 issue of the journal Proceedings of the National Academy of Sciences. The research could lead to new therapies for diabetes […]

Clients in the News – Saint Louis Univ. Scientists Take Aim at Diabetes, Obesity with Exercise in a Pill

  With a series of new grants, Saint Louis University researchers will tackle the twin epidemics of diabetes and obesity by tapping into the potential of two nuclear receptors that control muscle metabolism. The scientists will optimize two promising drug compounds, moving a step closer toward capturing the benefits of exercise in pill form. Thomas […]

Clients in the News – Baylor College and NIH: US Enrolls Volunteers in Large Test of Possible Zika Vaccine

U.S. health officials have begun enrolling volunteers for critical next-stage testing of an experimental vaccine to protect against Zika, the mosquito-borne virus that can cause devastating birth defects in pregnant women. The first volunteer was vaccinated Wednesday at Baylor College of Medicine in Houston, as the National Institutes of Health gears up for a two-part […]

Clients in the News – UVA – Artificial Pancreas Improves Blood Sugar Control in Young Kids

An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8 years, a new study finds. Results will be presented Tuesday at the Endocrine Society’s 99th annual meeting in Orlando, Fla. The “smart” artificial pancreas system, […]

Clients in the News – AstraZeneca, Circassia Enter Strategic Collaboration for Respiratory Disease

AstraZeneca announced it has entered a strategic collaboration with Circassia Pharmaceuticals plc, a respiratory biopharmaceutical company, for the development and commercialisation of Tudorza and Duaklir* in the US. Tudorza and Duaklir are inhaled respiratory medicines for the treatment of chronic obstructive pulmonary disease (COPD). Tudorza was approved and launched in the US in 2012. Duaklir […]

Clients in the News – Princeton Researchers Develop Technique to Track Yellow Fever Virus Application

Researchers from Princeton University’s Department of Molecular Biology have developed a new method that can precisely track the replication of yellow fever virus in individual host immune cells. The technique, which is described in a paper published March 14 in the journal Nature Communications, could aid the development of new vaccines against a range of […]

Clients in the News – Georgia State Researcher Wins Grant to Develop Ebola Virus Drug

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus. “We still lack any approved drugs to […]

Clients in the News – Stanford University: Antibody Fights 5 Types of Pediatric Brain Tumors

An immunotherapy successfully and safely treated five different types of aggressive pediatric brain tumors in mice, according to a new study from researchers at Stanford University School of Medicine. The antibody, called Hu5F9-G4, works against a cellular “don’t eat me” signal called CD47. The anti-CD47 antibody causes immune cells to surround and destroy tumors while […]

Clients in the News – UMD Develops New Method that Enables Creation of Better Therapeutic Antibodies

Antibodies are the foot soldiers of our immune system. These specialized, Y-shaped proteins attach to bacteria and viruses, where they either block the pathogen’s activity directly, or signal the immune system’s cells to destroy the invader. The second function–the ability to target invaders for destruction–makes antibodies a tempting target for cancer and disease therapies. But […]

Clients in the News – Frederick company pitches new device for deadly disease detection

  Sputum — a nasty mix of saliva and mucus — doesn’t come up in polite conversation. But it is key to testing for tuberculosis, one of the deadliest infectious diseases on the planet. “Last year, TB surpassed HIV as the single greatest killer of all infectious diseases, globally,” said Michael Reinemann, the director of […]

Clients in the News – UCLA: Nearly $9M in NHLBI Funding to Help Take Science Solutions to Heart

Thus far in 2017, the University of California Los Angeles has received over $6.8 million in funding from the National Heart Lung and Blood Institute (NHLBI). This funding has been awarded through multiple grants intended to support cardiovascular research. Some of the projects aimed at finding new scientific solutions to cardiovascular issues include: A study […]

Clients in the News – NIH Grants Akonni $300K to Develop DNA Extraction Device for Molecular TB Testing

akonni

Molecular diagnostics firm Akonni Biosystems won a $300,000 contract from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) to develop a low-cost, field-based device that can extract, purify, and stabilize DNA from sputum for molecular-based tuberculosis testing. The technology will need to be robust enough to use in inhospitable tuberculosis-endemic areas, and NIH says […]

Clients in the News – UC San Diego Receives Two, $2M Research Grants from CIRM

The California Institute for Regenerative Medicine (CIRM) awarded two scientists at UC San Diego $2 million each for their innovative research. The first award went to Alysson R. Muotri, PhD, professor in the UC San Diego School of Medicine departments of Pediatrics and Cellular and Molecular Medicine. The funding will support studies of new treatments […]

Clients in the News – Maryland Cancer Discovery Incubator Finalists Announced

it

Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced the finalists for their Cancer Discovery Incubator Award: Alcamena Stem Cell Therapeutics Ibex Biosciences Midissia Therapeutics miRecule TeamedOn International “We are pleased to announce five finalists for our unique cancer discovery incubator,” said Teri Heiland, Immunomic Vice President of Research and Development. “With a […]

Clients in the News – Duke University Engineers Use Tumor-Seeking Salmonella Treats Brain Tumors

Biomedical engineers at Duke University have recruited an unlikely ally in the fight against the deadliest form of brain cancer—a strain of salmonella that usually causes food poisoning. Clinicians sorely need new treatment approaches for glioblastoma, the most aggressive form of brain cancer. The blood-brain barrier—a protective sheath separating brain tissue from its blood vessels—makes […]

Clients in the News – Personal Genome Diagnostics’ ImmunoSELECT™ Technology Demonstrates How Resistance to Checkpoint Blockade Therapy Evolves in Cancer Discovery Study

–ImmunoSELECT’s Comprehensive Multi-Dimensional Genomic Analyses Elucidated How the Cancer Neoantigen Landscape Evolved During Treatment with Immuno-Oncology Therapy– Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced that its ImmunoSELECT™ technology played a key role in a major new immuno-oncology (IO) study published in Cancer Discovery. The […]

Clients in the News – University of Massachusetts: $4M Grant for Plant Stem Cell Research

Dr. Madelaine Bartlett, a biologist at the University of Massachusetts in Amherst, recently received a four-year $4 million grant from the National Science Foundation. The new research funding will allow Barlett and colleagues from UMass and other institutions to study the genes that regulate plant stem cell biology and their effect on fruit size and […]

Clients in the News – Immunomic Therapeutics Announces Board Addition

it

Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, announces that C. Eric Winzer, M.B.A., currently serving Immunomic as Chief Financial Officer, will join the Board of Directors. “Mr. Winzer’s keen financial expertise and broad industry experience will be a valuable addition to the Immunomic Board of Directors,” announced Immunomic CEO, Dr. William Hearl. “The […]